AstraZeneca Pharma India to Close Bengaluru API Unit

New Delhi: Drug firm AstraZeneca Pharma India will close its Active Pharmaceutical Ingredient (API) unit at Bengaluru due to low demand for the product in the export markets. The board of directors of the company at its meeting held on December 2, 2015 has decided to close the active pharmaceutical ingredient (API) Unit at Yelahanka in Bengaluru, AstraZeneca Pharma India said in a filing to BSE. The company, however, did not disclo...